Why is Chemo Pharma Lab falling/rising?

As of 04-Jul, Chemo Pharma Laboratories Ltd is currently priced at 112.45, showing no change (0.00%). The stock's performance today is inline with the sector, but it has experienced a significant decline over the past month, down 15.83%, while the benchmark Sensex has increased by 3.01%. Additionally, the stock is trading higher than its 200-day moving average but lower than its 5-day, 20-day, 50-day, and 100-day moving averages. Notably, there has been a drastic drop in investor participation, with delivery volume on July 3 falling by 99.59% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.
In the broader market context, Chemo Pharma's short-term return of -2.64% over the past week contrasts sharply with the Sensex, which has only declined by 0.74%. This suggests that the stock is underperforming relative to the market in the short term. Despite a strong performance over the longer term, with a year-to-date increase of 2.38% compared to the Sensex's 6.77%, the recent trends indicate a concerning decline in investor interest and participation, which could be influencing the stock's current price stability.